Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
In this extensive review, Zoghbi et al (1) focus on the effects of medications on stress myocardial perfusion imaging. Anti-ischemia medications may decrease the size of perfusion defects, cause fals-negative results, and decrease the diagnostic accuracy of the test. On the other hand, improvement in perfusion pattern has been associated with a decrease in the risk of cardiac death or myocardial infarction, especially in patients with a severely abnormal baseline study. After discussing some technical issues, the authors summarize the available evidence based on both experimental and clinical studies for nitrates, beta-blockers, calcium channel blockers and lipid-lowering agents. Also the results of two recent trials, the INSPIRE trial and the COURAGE nuclear substudy are discussed.
This review gives an up-to-date summary of the available data regarding anti ischemic medications and may help clinicians to decide when to discontinue cardiac medications before stress patients in patients that are evaluated for diagnostic purposes.
© 2017 European Society of Cardiology. All rights reserved